![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 3
Zeitschriftenartikel
Ben Khaled, Najib; Hammer, Katharina; Ye, Liangtao; Alnatsha, Ahmed; Widholz, Sebastian A.; Piseddu, Ignazio; Sirtl, Simon; Schneider, Julia; Munker, Stefan; Mahajan, Ujjwal Mukund; Montero, Juan Jose; Griger, Joscha; Mayerle, Julia; Reiter, Florian P. und De Toni, Enrico N.
(2022):
TRAIL Receptor Targeting Agents Potentiate PARP Inhibitor Efficacy in Pancreatic Cancer Independently of BRCA2 Mutation Status.
In: Cancers, Bd. 14, Nr. 21
[PDF, 2MB]
Kaltenbacher, Thorsten; Löprich, Jessica; Maresch, Roman; Weber, Julia; Müller, Sebastian; Oellinger, Rupert; Gross, Nina; Griger, Joscha; Andrade Krätzig, Niklas de; Avramopoulos, Petros; Ramanujam, Deepak; Brummer, Sabine; Widholz, Sebastian A.; Bärthel, Stefanie; Falcomata, Chiara; Pfaus, Anja; Alnatsha, Ahmed; Mayerle, Julia; Schmidt-Supprian, Marc; Reichert, Maximilian; Schneider, Günter; Ehmer, Ursula; Braun, Christian J.; Saur, Dieter; Engelhardt, Stefan und Rad, Roland
(2022):
CRISPR somatic genome engineering and cancer modeling in the mouse pancreas and liver.
In: Nature Protocols, Bd. 17, Nr. 4: S. 1142-1188
Falcomata, Chiara; Baerthel, Stefanie; Widholz, Sebastian A.; Schneeweis, Christian; Montero, Juan Jose; Toska, Albulena; Mir, Jonas; Kaltenbacher, Thorsten; Heetmeyer, Jeannine; Swietlik, Jonathan J.; Cheng, Jing-Yuan; Teodorescu, Bianca; Reichert, Oliver; Schmitt, Constantin; Grabichler, Kathrin; Coluccio, Andrea; Boniolo, Fabio; Veltkamp, Christian; Zukowska, Magdalena; Vargas, Angelica Arenas; Paik, Woo Hyun; Jesinghaus, Moritz; Steiger, Katja; Maresch, Roman; Oellinger, Rupert; Ammon, Tim; Baranov, Olga; Robles, Maria S.; Rechenberger, Julia; Kuster, Bernhard; Meissner, Felix; Reichert, Maximilian; Flossdorf, Michael; Rad, Roland; Schmidt-Supprian, Marc; Schneider, Guenter und Saur, Dieter
(2022):
Selective multi-kinase inhibition sensitizes mesenchymal pancreatic cancer to immune checkpoint blockade by remodeling the tumor microenvironment.
In: Nature Cancer, Bd. 3, Nr. 3: S. 318-336